Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Therapeutic insights into the treatment of Osteoporosis: Stress-induced gene product p53 increases the expression of a bone formation inhibitor Sclerostin via up regulation of its target gene, 11/September/2014, 06.04 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at email@example.com
* Research cooperation
Significance: This study suggests, for the first time, that stress-responsive protein p53 may inhibit bone formation. Thus, pharmacological formulations encompassing “p53 inhibitor” may be used to treat Osteoporosis.